|
PARP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.975550E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.659900E-03 |
| Normal-vs-Stage2 |
2.197800E-01 |
| Normal-vs-Stage3 |
6.375200E-04 |
| Normal-vs-Stage4 |
3.141900E-03 |
| Stage1-vs-Stage2 |
3.771000E-01 |
| Stage1-vs-Stage3 |
1.007760E-01 |
| Stage1-vs-Stage4 |
1.921570E-01 |
| Stage2-vs-Stage3 |
5.966400E-02 |
| Stage2-vs-Stage4 |
9.355600E-02 |
| Stage3-vs-Stage4 |
9.557800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.195300E-03 |
| Normal-vs-AfricanAmerican |
3.395600E-01 |
| Normal-vs-Asian |
8.658500E-03 |
| Caucasian-vs-AfricanAmerican |
2.798000E-01 |
| Caucasian-vs-Asian |
6.348800E-01 |
| AfricanAmerican-vs-Asian |
1.759580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.159300E-03 |
| Normal-vs-Female |
2.495500E-03 |
| Male-vs-Female |
5.312000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.248280E-02 |
| Normal-vs-Age(41-60Yrs) |
3.984100E-04 |
| Normal-vs-Age(61-80Yrs) |
2.962300E-02 |
| Normal-vs-Age(81-100Yrs) |
7.938400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.740400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.613000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.467200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.750400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.347000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.707400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.696200E-02 |
| Classical-VS-Follicular |
9.884000E-01 |
| Classical-VS-Other |
2.226200E-01 |
| Classical-VS-Normal |
6.736900E-03 |
| Tall-VS-Follicular |
3.398300E-02 |
| Tall-VS-Other |
9.249000E-01 |
| Tall-VS-Normal |
2.154700E-04 |
| Follicular-VS-Other |
3.073800E-01 |
| Follicular-VS-Normal |
4.157800E-02 |
| Other-VS-Normal |
4.967500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.610070E-02 |
| Normal-vs-N1 |
4.98400000004118E-06 |
| N0-vs-N1 |
1.821490E-03 |
|
|
